Suppr超能文献

在有和没有波形蛋白中间丝的情况下,SW13细胞中糖鞘脂生物合成途径。

Pathways of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments.

作者信息

Gillard B K, Harrell R G, Marcus D M

机构信息

Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

Glycobiology. 1996 Jan;6(1):33-42. doi: 10.1093/glycob/6.1.33.

Abstract

We reported previously that the incorporation of sugars into glycosphingolipids (GSL) is diminished in SW13 cells that lack a vimentin intermediate filament (IF) network (vim-) compared to vim+ cells. To further analyze the nature of this abnormality, we double-labeled cells with 3H-serine and 14C-sugars. There was no difference between vim+ and vim- cells in the incorporation of serine into GSL, although the usual difference in sugar incorporation was observed. This indicated that the defect in vim- cells was not in the incorporation of sugars into ceramide synthesized de novo by acylation of sphinganine (pathway 1). Sugars can also be incorporated into ceramide synthesized from sphingosine that is derived from catabolism of sphingolipids (pathway 2), and into GSL that recycle through the Golgi apparatus from endosomes (pathway 3). The amount of galactose and glucosamine incorporated into GSL in these three pathways was analyzed by the use of two inhibitors of sphingolipid biosynthesis. beta-Chloroalanine inhibits the de novo synthesis of sphinganine (pathway 1), and fumonisin B1 inhibits the acylation of sphinganine and sphingosine (pathways 1 and 2). We were surprised to observe that in both vim+ and vim- cells only 20-40% of sugar incorporation into GSL took place in pathway 1, and 60-80% of sugar incorporation took place in the recycling pathways. Moreover, in contrast to larger GSL, GlcCer was not synthesized in pathway 3. Our observations indicate that vimentin IF facilitate the recycling of GSL and sphingosine, and that the differences between vim+ and vim- cells are predominantly in pathways 2 and 3. Furthermore, although it is generally believed that virtually all GSL are synthesized in the de novo pathway, these data indicate that the recycling pathways predominate in the incorporation of sugars into GSL in SW13 cells.

摘要

我们之前报道过,与表达波形蛋白中间丝(IF)网络的细胞(vim+)相比,缺乏波形蛋白中间丝网络的SW13细胞(vim-)中糖掺入糖鞘脂(GSL)的过程减少。为了进一步分析这种异常的本质,我们用³H-丝氨酸和¹⁴C-糖对细胞进行了双重标记。波形蛋白阳性和阴性细胞在丝氨酸掺入GSL方面没有差异,尽管观察到了糖掺入方面的通常差异。这表明波形蛋白阴性细胞的缺陷不在于通过鞘氨醇酰化从头合成神经酰胺过程中糖的掺入(途径1)。糖也可以掺入由鞘脂分解代谢产生的鞘氨醇合成的神经酰胺中(途径2),以及从内体通过高尔基体循环的糖鞘脂中(途径3)。通过使用两种鞘脂生物合成抑制剂分析了这三条途径中掺入GSL的半乳糖和葡糖胺的量。β-氯丙氨酸抑制鞘氨醇的从头合成(途径1),伏马菌素B1抑制鞘氨醇和鞘氨醇的酰化(途径1和2)。我们惊讶地发现,在波形蛋白阳性和阴性细胞中,只有20%-40%的糖掺入GSL发生在途径1中,而60%-80%的糖掺入发生在循环途径中。此外,与较大的糖鞘脂相比,葡糖神经酰胺不是在途径3中合成的。我们的观察结果表明,波形蛋白中间丝促进了糖鞘脂和鞘氨醇的循环,波形蛋白阳性和阴性细胞之间的差异主要存在于途径2和3中。此外,尽管通常认为几乎所有的糖鞘脂都是通过从头途径合成的,但这些数据表明,在SW13细胞中,糖掺入糖鞘脂的过程中循环途径占主导地位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验